Clinical trial · Interventional
Fasting Mimicking Diet With Chemotherapy in Patients With Leukemia
The Effect of Fasting Mimicking Diet With Chemotherapy on the Number of Blasts and Platelets and Quality of Life in Patients With Acute Lymphoid Leukemia and Acute Myeloid Leukemia
NCT06353698CI-TRIAL-00075833unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical trial is to investigate The effect of fasting mimicking diet with chemotherapy on the number of blasts and platelets and quality of life in patients with acute lymphoid leukemia and acute myeloid leukemia.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Fasting Mimicking Diet | — | UNRESOLVED | — |
| Leukemia | Leukemia | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| fasting mimicking diet | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- fasting mimicking diet
- description
- the intervention group that receive fasting mimicking diet with chemotherapy
- interventionNames
- Dietary Supplement: fasting mimicking diet
- type
- NO_INTERVENTION
- label
- control
- description
- the control group that receive chemotherapy without any intervention
Primary outcomes (2)
- measure
- Blast cell count
- timeFrame
- at 4th week
- description
- the number of blast cell in perpheral blood
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * People who have recently been diagnosed with acute leukemia pathology and have been prescribed chemotherapy * Willingness to cooperate * BMI \>18.5 Exclusion Criteria: * diabetes * metastases to other organ * Unwillingness to continue the study by patients
References
Publications (0)
Data not yet available
No reference posted for this study.